Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis

Summary

The study will assess the efficacy and safety of SPARC1310 when compared to placebo and active control

Timeline

Start

2014-10

Primary completion

2014-12

Completion

2014-12

Outcome

Met primary endpoint

paper Improvement in TNSS from baseline to day 14 was statistically significant in all S0597 groups compared with placebo. PMID 27613466 ↗

Publications

• Ellis AK, Steacy LM, Joshi A, Bhowmik S, Raut A. Efficacy of the novel nasal steroid S0597 tested in an environmental exposure unit. Ann Allergy Asthma Immunol. 2016 Sep;117(3):310-7. doi: 10.1016/j.anai.2016.07.018.

Drugs

Indications